tradingkey.logo
tradingkey.logo
Search
avatar

PRIMECAP Management

PRIMECAP Management

PRIMECAP is a U.S. asset management firm focused on stock investments. Known for its unique investment strategies and low-profile operating style, it buys undervalued stocks during market downturns and gradually exits as value is realised.

Shares Held
Asset Size
% Top 10
441
$136.33B
31.38%
Latest2025Q3
Top BuysAAL (US)
Top Sells--

Latest Changes

Indicators
Latest (2025Q3)
Previous (2025Q2)
Change
Mkt Value (report date)
136.33B
137.14B
-0.59%
Shares Held
441
416
+6.01%
Buys
85
63
+34.92%
Sells
194
244
-20.49%

Sector Allocation

No.
Name
% Portfolio
Shares Traded
Mkt Value (Date)
Market Value
Shares Held
Report Date
Watchlist
6.22%
-42.35K
$8.48B
$7.04B
9.22M
2026-03-31
5.42%
-2.92M
$7.39B
$3.66B
21.87M
2026-03-31
3.16%
-140.83K
$4.31B
$3.64B
14.99M
2026-03-31
2.63%
-4.38M
$3.59B
$26.29B
24.38M
2026-03-31
5
Astrazeneca Ord Shs (GB)
AZN
2.59%
+18.21M
$3.53B
$1.40B
18.21M
2026-03-31
2.45%
-370.30K
$3.34B
$2.54B
75.76M
2026-03-31
2.29%
-30.85K
$3.12B
$2.50B
8.87M
2026-03-31
2.24%
-1.34M
$3.06B
$3.06B
39.86M
2025-09-30
2.20%
-39.29K
$3.00B
$3.21B
17.19M
2026-03-31
2.17%
-209.66K
$2.96B
$1.58B
8.30M
2026-03-31

Latest Trades

No.
Name
Action
Shares Traded
% Change
Shares Held
Mkt Value (Date)
Report Date
Watchlist
Buy
+20.20M
+22.50%
69.19M
$1.01B
2026-05-31
AstraZeneca ADR Representing 0.5 Ord Shs ()
AZN
Exit
-36.92M
-100.00%
0.00
$0.00
2026-03-31
Astrazeneca Ord Shs (GB)
AZN
New
+18.21M
+50.00%
18.21M
$3.53B
2026-03-31
Buy
+10.87M
+22.40%
37.50M
$422.67M
2026-03-31
Buy
+6.14M
+45.60%
7.30M
$157.95M
2026-03-31
Sell
-4.38M
-15.20%
24.38M
$3.59B
2026-03-31
Buy
+3.81M
+15.00%
21.47M
$412.43M
2026-03-31
Sell
-2.92M
-11.70%
21.87M
$7.39B
2026-03-31
9
Glencore Ord Shs (GB)
GLEN
Sell
-2.36M
-4.70%
47.15M
$351.58M
2026-03-31

Holding Performance

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.